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The ATR protein is a member of the phosphoinositide 3-kinase-
related kinase family and plays an important role in UV-induced
DNA damage checkpoint response. Its role as a signal transducer in
cell cycle checkpoint is well established, but it is currently unclear
whether ATR functions as a damage sensor as well. Here we have
purified the ATR protein and investigated its interaction with DNA
by using biochemical analysis and electron microscopy. We find
that ATR is a DNA-binding protein with higher affinity to UV-
damaged than undamaged DNA. In addition, damaged DNA stim-
ulates the kinase activity of ATR to a significantly higher level than
undamaged DNA. Our data suggest that ATR may function as an
initial sensor in the DNA damage checkpoint response.
DNA damage checkpoint is the arrest in cell cycle progressionupon damage to cellular DNA. The checkpoint response,
conceptually, has three biochemical components: damage sen-
sors, signal transducers, and effector molecules (1–3). At
present, the damage-sensing step of checkpoint signaling is not
well understood. Thus, it is not clear whether primary lesions in
the form of UV photoproducts, base adducts, single-strand
nicks, double-strand breaks induced by UV, chemotherapeutic
drugs, and ionizing radiation are detected by the molecular
sensors that recognize one or more of these lesions or whether
all these lesions eventually create a common structure on
encounter with a replication fork, which then constitutes the
signal for the checkpoint. Similarly, the identity of the damage
sensors remains to be determined. Genetic and preliminary
biochemical analyses in human cell lines and budding and fission
yeasts indicate that ATM and ATR or the checkpoint Rad
proteins Rad17, Rad9, Rad1, and Hus1 in mammals and their
counterparts in yeasts may function as damage sensors (1, 2).
ATM and ATR belong to the phosphoinositide 3-kinase-
related kinase (PIKK) family of proteins. The PIKK members
are large proteins with Ser/Thr kinase activity serving important
roles in DNA repair and DNA damage checkpoint (1, 4). The
three PIKK proteins with repair and checkpoint functions in
mammalian cells are: DNA-dependent protein kinase (DNA-
PK), the kinase mutated in radiosensitive/genomic instability
syndrome ataxia telangiectasia (ATM, A-T mutated), and ATR
(ATM and Rad3 related) (see ref. 5). DNA-PK participates in
V(D)J recombination and repair of double-strand breaks by
nonhomologous end joining; it is a heterotrimer of DNA-PKcs (a
PIKK member), Ku70, and Ku86, and it binds to DNA ends
through the Ku70/Ku86 heterodimer. The role of DNA-PK in
end joining is relatively well understood, but the physiological
relevance of its kinase activity is unclear at present. In contrast,
the physiological consequences of protein phosphorylation by
ATM and ATR are reasonably well defined, but the DNA-
binding activities of these proteins and their relevance to the
ATM/ATR functions remain ill defined. Upon DNA damage (by
ionizing radiation for ATM and by UV for ATR), both proteins
phosphorylate p53 and the signal transduction kinases Chk1 and
Chk2. However, there are no convincing data that ATM and
ATR are recruited to the site of damage by functional homologs
of the Ku70/Ku86 complex. It has been postulated that the
mammalian checkpoint Rads (Rad17, Rad9, Rad1, and Hus1)
may be the damage sensors functioning upstream of the ATM
and ATR kinases (1, 5).
The checkpoint Rads are expected to form protein complexes
that are the structural homologs of the Replication Factor C
(RFC)/proliferating cell nuclear antigen (PCNA) clamp loader/
replication clamp but with a specialized role in the DNA damage
checkpoint response. Thus, it has been proposed that Rad17
forms a heteropentameric complex in which the large subunit of
RFC (p140) is replaced by Rad17 (6–8). Similarly, molecular
modeling studies have led to the proposal that Rad9, Rad1, and
Hus1 form a heterotrimeric checkpoint sliding clamp or 9–1-1
complex similar to PCNA (9–11). In vivo (12–15) and in vitro (16)
biochemical studies have supported the presence of the Rad17-
RFC checkpoint clamp-loading complex and of the Rad9-Rad1-
Hus1 checkpoint sliding clamp complex, and of the presence of
a DNA damage checkpoint complex comprising the Rad17-RFC
and the checkpoint 9–1-1 complexes (16). However, at present
there is no biochemical evidence that these complexes recognize
either primary or secondary DNA lesions or repair intermedi-
ates that may be the checkpoint-activating structures.
In this paper, we have attempted to address two questions:
whether the primary UV lesion in the form of unprocessed
photoproduct can act as a signal for checkpoint activation, and
whether the ATR protein can initiate the checkpoint signaling
cascade by directly binding to and becoming activated by UV
photoproducts. Our results indicate that ATR directly binds to
UV-damaged DNA with higher affinity than undamaged DNA,
and that this interaction increases its kinase activity toward p53.
These results are consistent with the notion that, at least under
certain circumstances, unprocessed lesions can initiate DNA
damage checkpoint response and that ATR may function as
damage sensor in DNA damage checkpoint response to UV.
Materials and Methods
Cell Culture and Antibodies. The simian virus 40-transformed
human embryonic kidney (HEK)293T cells were maintained in
DMEM (GIBCO/BRL) supplemented with 10% FBS and 100
units of penicillin and streptomycin/ml. Mouse monoclonal
anti-Flag antibody was obtained from Sigma.
Plasmid Constructs. Two Flag-ATR constructs containing the
full-length cDNA clone of human ATR and its kinase-dead
version (K2327R) in pcDNA3 (Invitrogen) expression vector
were kindly provided by R. T. Abraham [Duke University (17)].
By using PCR, various regions of the cDNA encoding ATR were
amplified (see delineation of the regions in Fig. 1). In each case,
the 5 primer contained an ATG codon followed by a Flag-
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epitope in frame with the coding region that was amplified.
These PCR products were digested with BamHI and XhoI
restriction enzymes and ligated into pcDNA4.1 (Invitrogen)
expression vector through the same enzyme sites to generate the
N-terminal Flag epitope-tagged ATR fragments.
Transfections and Cell Lysis. Transfections were carried out by
using the calcium phosphate method. For transfections, 8  106
293T cells were plated per 225 cm2 flask and allowed to grow for
24 h. Plasmid DNA (25 g) was mixed with CaCl2, and this
mixture was added to a 2  HEBS (140 mM NaCl/1.5 mM
Na2HPO4/50 mM Hepes, pH 7.05) solution and incubated for 8
min at room temperature. The CaCl2/DNA/HEBS precipitate
was then added dropwise to the cell medium. After 16-h
incubation at 37°C in 5% CO2, cells were washed twice in
serum-free DMEM and fresh media added to the cells for a
further 48 h of incubation. Cells were lysed in ice-cold lysis buffer
[50 mM Tris, pH 7.5/150 mM NaCl/10 mM -glycerophosphate/
10% glycerol/1% Tween-20/0.1% Nonidet P-40/1 mM Na3VO4/1
mM NaF and protease inhibitors (Roche Molecular Biochemi-
cals)] for 30 min. The cell lysates were centrifuged for 30 min at
32,000  g or frozen in dry ice and stored at 80°C until use.
Protein Purification. The supernatants from the spun lysates were
incubated at 4°C for at least 4 h with anti-FLAG M2 affinity gel
(Sigma) that had been preequilibrated in TBS buffer (50 mM
TrisHCl, pH 7.5/150 mM NaCl). The beads were then washed
once with 1 M NaCl containing TBS buffer and three times with
150 mM NaCl containing TBS. The ATR bound to beads was
either used directly for pull-down experiments or eluted with
TBS buffer containing 200 g/ml FLAG peptide (Sigma).
Human p53 protein overexpressed in SF9 cells was generated
in the laboratory of J.D.G., as described (18).
DNA Substrates. Duplex DNAs of 46 bp, containing a single
T[6–4]T photoproduct and its unmodified version, were pre-




The T[6–4]T photoproduct containing substrate was con-
structed by ligating the damage-containing oligomer (8-mer),
which was 5-terminally labeled, with other partially overlapping
oligonucleotides to obtain the internally labeled duplex as de-
scribed (19, 20). The resulting 46-bp duplex contains the (6–4)
photoproduct at positions 23 and 24. The full-length duplexes
were separated from the ligation mixture by gel purification
through 5% nondenaturing polyacrylamide gel. These substrates
were used for pull-down assays. For protein–DNA crosslinking
experiments, a 50-mer substrate with an azidophenacyl photo-
sensitizer of the following sequence was used:
5-gcgccagctggccaccctgagaagctacgagcgagcgccaagcttgggct-3.
These 50-mer duplex DNAs were purchased from Operon
Technologies (Alameda, CA). The azidophenacyl moiety was
coupled to the oligonucleotide as described (21).
For electron microscopy and kinase assays, pGEMEX1
dsDNA cooled on ice in a microtiter plate was irradiated with
254-nm light at a rate of 1 mW/cm2 by using a germicidal UV-C
(254-nm) lamp (General Electric).
Electron Microscopy. Fifty nanograms of ATR protein was incu-
bated with 200 ng of linearized or supercoiled pGEMEX1
dsDNA in kinase buffer containing 25 mM Hepes, pH 7.9, 50
mM KCl, 10 mM MgCl2, 2 mM MnCl2, 20% glycerol, 0.1%
Nonidet P-40, 1 mM DTT, and 0.5 mg/ml of BSA for 15 min at
30°C. After incubation, DNA–protein complexes were fixed with
0.6% glutaraldehyde for 10 min at 20°C. The reaction mixture
was chromatographed on 2 ml of BioGel A5m (BioRad), equil-
ibrated with TE buffer (10 mM TrisHCl/1 mM EDTA, pH 8.0)
to remove fixatives and unbound protein. The fractions contain-
ing DNA–protein complexes were collected and prepared for
electron microscopy as described (22) and analyzed by using a
Philips (Eindhoven, The Netherlands) CM12 electron micro-
scope. The images were scanned by using a Nikon-4500 film
scanner and contrast adjusted by using Adobe PHOTOSHOP
software (Adobe Systems, Mountain View, CA). The size of
protein particles bound to DNA was estimated as described
elsewhere (23).
Fig. 1. Purification of full-length and various fragments of ATR from tran-
siently transfected HEK293T cells. (A) Schematic representation of the full-
length ATR (ATR-F) and its N-terminal (ATR-N), middle region (ATR-M), and
C-terminal (ATR-C) fragments. (B) Recombinant wild-type (wt) and kinase-
dead (kd) ATR, each containing a Flag affinity tag, purified from HEK293T
cells, were separated by SDS/PAGE and visualized by silver staining shown
(Left). Western blot of the ATR preparations with an antibody specific for the
N-terminal FLAG tag is shown (Right). For the kinase activity of recombinant
wild-type and kinase-dead ATR, purified proteins were incubated with [-32P]-
ATP, and reaction products were electrophoresed and visualized by silver
staining (Bottom) or autoradiography (Top). (C) Expression of Flag-epitope
tagged and affinity-purified ATR-fragments as analyzed by silver staining.
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Pull-Down Assays. The Flag-ATR protein bound to the beads was
washed first with the kinase buffer and then incubated with
internally radiolabeled DNA substrates at 30°C for 30 min in a
reaction buffer of 25 l. The beads were washed three times with
0.1% Nonidet P-40 containing TBS buffer at 4°C. The DNA-
bound ATR on the beads was either loaded onto 10% SDS/
PAGE or eluted with TBS buffer containing 200 g/ml of FLAG
peptide (Sigma) and then visualized by silver staining. The
amount of DNA bound to ATR was measured with a Phospho-
rImager and the IMAGEQUANT system (Molecular Dynamics) by
comparing the radioactivity bound to ATR-containing resin to
the radioactivity in control lanes containing known amounts of
DNA.
Protein–DNA Crosslinking. Azidophenacetyl-derivatized DNA (2
fmol) was incubated with approximately 100 ng of ATR in 10 l
of kinase buffer at 30°C for 30 min. Reaction mixtures were
transferred to a microtiter plate and irradiated with a 366-nm
light from BLB lamps (General Electric) at a rate of 1 mW/cm2
at a distance of 5 cm. The samples were covered with the
polystyrene lid of the microtiter plate to shield them from
wavelengths below 300 nm and cooled on ice during illumination.
Crosslinked proteins were resolved on 7.5% SDS/PAGE, and
gels were silver stained, dried, and exposed to film.
Kinase Assays. Kinase assays were performed in 20-l reactions by
using 50 ng of purified ATR, 50 ng of purified p53, and linearized
pGEMEX1 DNA with and without UV treatment at the indi-
cated concentrations in a kinase buffer containing 25 mM
Hepes, pH 7.9, 50 mM KCl, 10 mM MgCl2, 2 mM MnCl2, 20%
glycerol, 0.1% Nonidet P-40, 1 mM DTT, and 0.5 mg/ml of BSA.
ATR and DNA mixtures were incubated on ice for 5 min before
substrate and ATP addition. ATP was added to a final concen-
tration of 50 M along with 5 Ci[-32P]-ATP. Reaction mix-
tures were incubated at 30°C for 30 min. Phosphorylated pro-
teins were subjected to 10% SDS/PAGE, visualized by silver
staining, and exposed on a Molecular Dynamics PhosphorIm-
ager screen for quantitation by IMAGEQUANT software.
Results
Purification of Full-Length ATR and ATR Fragments for DNA–Protein
Interactions. We wished to determine whether ATR interacts
directly with DNA and if it does, whether this interaction is
confined to a specific domain within the protein. Fig. 1 A
schematically shows the organization of the ATR protein (24).
This large protein contains a limited number of sequence motifs
as indicated: these include an N-terminal leucine-rich domain,
an ATM homology domain of about 100 amino acids in its
middle region, and a C-terminal domain with homology to PIKK
family proteins, which contains the kinase active site residues. To
investigate ATR-DNA interaction and the effect of this inter-
action on kinase activity, we used FLAG-tagged wild-type and
kinase-dead ATR constructs in a mammalian expression vector
as described (17, 25) as well as FLAG-tagged constructs ex-
pressing the N-terminal half (N), the middle (M), and the
C-terminal half (C) of the protein as indicated in Fig. 1 A. First
we purified the full-length wild-type and kinase-dead ATR by
affinity chromatography and tested them for purity by SDS/
PAGE and silver staining and for activity by an autophosphor-
ylation assay. As seen in Fig. 1B, the proteins are of high purity,
and the kinase-dead mutant does not exhibit detectable kinase
activity in our assay. Fig. 1C shows the expression of the ATR
fragments on transfection of HEK293T cells with the appropri-
ate constructs. In general, we found that the ATR full-length,
ATR-N, and ATR-M proteins were expressed at comparable
levels, but ATR-C was expressed at a significantly lower amount.
Binding of ATR to DNA. Analysis of ATR-DNA binding by con-
ventional electrophoretic mobility-shift assay in conjunction
with ‘‘supershift’’ by anti-ATR antibodies indicated that ATR
directly binds DNA (data not shown). However, because of the
large size of the protein, data obtained by this method were
qualitative and variable. Therefore we used a ‘‘pull-down’’ assay
to analyze ATR–DNA interactions. HEK293T cells transfected
with vectors expressing full-length ATR or ATR fragments were
lysed, and the tagged ATR proteins were purified by binding to
FLAG-agarose beads. Radiolabeled DNA was added to the
beads and, after incubation and exhaustive washes, the proteins
on the beads were released with SDS, visualized by silver
staining, and the DNA was detected by autoradiography. Fig. 2
Top shows the relative levels of ATR and its derivatives on the
beads. The full-length protein and the N-terminal and middle
fragments are expressed at comparable levels and the C-terminal
fragment is at a lower amount. Fig. 2 Middle shows the autora-
diographic analysis of bound DNA and Bottom shows the
quantitative analysis of the data from Middle. It appears that only
full-length ATR binds DNA as the amount of DNA associated
with ATR fragments is not above background. Although the use
of those fragments in the pull-down experiment shows that ATR
fragments alone cannot bind to DNA, the presence of ATR
fragments on the beads confirms the specificity of full-length
ATR interaction with DNA, indicating that the full-length ATR
interaction with DNA is not a result of nonspecific binding of
DNA onto resins.
Our ATR preparations are quite pure (see Fig. 1), and
therefore the most likely explanation of the data in Fig. 2 is that
ATR directly binds DNA. However, it was conceivable that
binding was mediated by small quantities of a contaminant not
detectable by our analyses. Therefore, we wished to confirm
Fig. 2. ATR binds DNA. HEK293T cells were transfected with vector express-
ing full-length ATR (ATR-F), its N-terminal (ATR-N), middle region (ATR-M),
and C-terminal (ATR-C) fragments or the nontransfected (Mock) cells were
lysed and the tagged proteins were purified by binding to FLAG-agarose
beads. The beads were then incubated with radiolabeled DNA substrate as
described in Materials and Methods. After exhaustive washing, the beads
were loaded onto a 10% SDS/PAGE, and the bound proteins were visualized
by silver staining (Top), and the levels of ATR-bound substrates were visualized
by autoradiography (Middle). Bottom shows the quantitative analysis of data
from Middle.








direct ATR-DNA binding by photocrosslinking. DNA–protein
crosslinking by UV occurs only when the two are in direct
contact, and therefore this method is referred to as ‘‘zero-
distance’’ crosslinking (26). To perform UV crosslinking, full-
length ATR and ATR fragments were purified, mixed with
azidophenacetyl derivatized and radiolabeled DNA, and ex-
posed to 366-nm light. The reaction products were separated on
an SDS/PAGE, which was then analyzed by silver staining (Fig.
3A), and autoradiography (Fig. 3B). We find that full-length
ATR is crosslinked to DNA, whereas the ATR fragments are not
(Fig. 3B). Thus, we conclude that ATR is a DNA-binding
protein, and that either the DNA binding requires amino acids
from the entire protein or the fragments we have expressed are
not in a conformation conducive to bind DNA.
Preferential Binding of ATR to UV (6–4) Photoproduct. An important
question in the field of DNA damage checkpoint is the identity
of the signal initiating the checkpoint cascade. Although it is
generally believed that lesions processed by the replication or
repair systems generate a common structure that is recognized
by the DNA damage checkpoint pathway, the possibility exists
that under certain circumstances the damage per se is bound by
the sensor. UV induces two major photoproducts in DNA:
cyclobutane pyrimidine dimers, which make up 80–90% of the
lesions, and (6–4) photoproducts, which constitute 10–20% of
the damage. Cyclobutane pyrimidine dimers, in contrast to (6–4)
photoproducts, are poorly recognized by damage sensors in-
volved in DNA repair (27), and we reasoned that the same may
be true for the damage sensors in checkpoint response as well.
Therefore, we compared the binding of ATR to an oligomer of
46 bp with and without a (6–4) photoproduct by using the
pull-down assay. As shown in Fig. 4, ATR has a significantly
higher affinity for the oligomer with the (6–4) photoproduct.
Considering that a single photoproduct increases the affinity of
ATR to the 46-mer 1.6-fold, it is calculated that ATR has about
46  1.680-fold higher affinity to a (6–4) photoproduct
relative to an undamaged dinucleotide.
Analysis of ATR-DNA Complexes by Electron Microscopy. Solution
studies on ATR-DNA interaction were complemented by elec-
tron microscopy. Fig. 5A shows representative pictures of ATR-
DNA complexes. The protein binds with equal affinity to linear
and supercoiled DNA; under our assay conditions, 10% of
supercoiled or linear DNA molecules were bound by ATR (Fig.
5A). It appears that ATR is a globular monomeric protein with
no special affinity for DNA ends. However, in about half of the
micrographs, the protein was seen bound to two DNA segments,
indicating that ATR may have two DNA-binding sites or that
alternatively two monomers bound to different regions of the
DNA molecule bringing these regions into proximity by protein–
protein interaction. Obviously, this point deserves further inves-
tigation by other methods.
In addition to providing information regarding the size and the
shape of ATR, electron microscopy also enabled us to measure
the affinity of ATR to damaged DNA by an independent
method. Unirradiated or UV-irradiated plasmid DNA was
mixed with ATR, and the fractions of DNA molecules with
bound ATR were scored. As seen in Fig. 5B, gradually more
ATR is bound to DNA with increasing UV dose. Thus, this
experiment, combined with the pull-down assay shown in Fig. 4,
strongly suggests that this binding may enable ATR to act as a
sensor in the DNA damage checkpoint cascade.
Stimulation of ATR Kinase Activity by DNA Damage. If specific
binding of ATR to DNA damage is an early step in the
UV-induced DNA damage checkpoint response, DNA damage
might be expected to modulate the kinase activity of ATR. To
test this prediction, ATR was incubated with one of its better
known substrates, p53, in the presence of undamaged and
UV-damaged DNA (Fig. 6A). There is a high basal level of p53
phosphorylation in the absence of DNA, which is stimulated by
DNA (28) and to a significantly higher level by UV-damaged
Fig. 3. UV crosslinking of full-length ATR with DNA. Purified full-length ATR
(ATR-F) and its fragments, ATR-N, ATR-M, and ATR-C, were mixed with the
azidophenacetyl-derivatized DNA probe, and the reaction mixtures were
exposed to 366-nm light on ice. The reaction products were separated by
SDS/PAGE and analyzed by (A) silver staining and (B) autoradiography.
Fig. 4. ATR preferentially binds to UV (6–4) photoproduct. HEK293T cells
transfected with a vector expressing full-length ATR or no transfected (Mock)
cells were lysed and the tagged proteins were purified by binding to FLAG-
agarose beads. Proteins bound to beads were incubated with either unmod-
ified (U) 46-mer duplex or (6–4)-photoproduct containing duplex of the same
sequence (M). After extensive washing, the material bound to the beads was
analyzed by SDS/PAGE followed by silver staining (Top) and autoradiography
(Middle). The input lanes contain 1/10th of the DNA used in the binding assay.
Bottom shows the mean values and standard errors of DNA binding calculated
from three independent experiments.
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DNA (Fig. 6B). Thus, our data are consistent with the notion
that ATR is a damage sensor and is directly activated by the
primary DNA lesion.
Discussion
In this study, we have investigated the role of ATR as a damage
sensor in DNA damage checkpoint response. Our results show
that ATR directly recognizes UV damage and, as a result of
binding to UV lesions, its kinase activity is stimulated about
2-fold. The discrimination by ATR between damaged and un-
damaged DNA is modest, and hence it may be asked whether
such low selectivity is sufficient to confer a damage sensor
function to ATR. Although this is a legitimate concern, it must
be pointed out that well characterized damage recognition
proteins XPA, RPA, and XPC, which are necessary and suffi-
cient to confer high specificity to human excision nuclease,
display a similar preference for DNA as that of ATR (29). It has
been suggested that the modest discriminatory power of the
damage recognition proteins of the nucleotide excision repair
system is amplified by cooperative action of these proteins and
by the kinetic proofreading mechanism (30), which results from
the differential stability of the excision nuclease subassemblies
that form on damaged compared with undamaged DNA. The
same kinetic discrimination is known to occur by the damage
recognition proteins of Escherichia coli excision nuclease. In fact,
modest discriminatory power between target and nontarget
sequences is a common theme in eukaryotic DNA acting pro-
teins, and high specificity is achieved by either combinatorial
action of multiple factors as often occurs in transcriptional
regulation (31), or by a kinetic proofreading mechanism (30)
such as the one operative in nucleotide excision repair, where
low-specificity ATP-independent damage recognition is ampli-
fied by subsequent recruitment of ATPase/helicases that aid in
the formation of high-specificity complexes (29). Currently it is
unclear whether checkpoint sensors achieve high specificity by a
combinatorial mechanism or by a kinetic proofreading mecha-
nism. Regardless of the specifics, our data strongly suggest that
ATR can directly bind to DNA and, by virtue of its higher affinity
for damaged DNA, it may function as a sensor that recognizes
the primary DNA lesion.
The prototype of the PIKK family, the DNA–PKcs, is re-
cruited to DNA ends by the Ku heterodimer, and it has been
speculated that other members of this family may also possess
Ku-like small subunits with the potential of binding to DNA and
recruiting the large cognate PIKK. Indeed, after this work was
completed, a paper was published showing that ATR is in
association with a 90-kDa protein named ATRIP (32). It appears
that ATRIP is important for the stability of ATR in vivo.
However, whether ATRIP affects any of the ATR functions is
Fig. 5. ATR-DNA binding analyzed by electron microscopy. (A) Visualization
of the binding of ATR protein to (a) linearized or (b) supercoiled pGEMEX1
dsDNA. The samples were directly mounted onto thin carbon-coated foils and
rotary shadowed with tungsten. The complexes shown in a and b are repre-
sentatives of the total population of protein-bound DNA molecules observed.
(Bar  250 nm.) (B) Quantitative comparison of ATR DNA binding to unirra-
diated or UV-irradiated plasmid DNA. The number of protein–DNA complex is
given in relation to the number of DNA molecules counted in each reaction.
Fig. 6. Phosphorylation of p53 by purified ATR is stimulated by damaged
DNA. (A) Kinase reactions were performed with p53 alone (lane 1) or p53 and
ATR in the absence of DNA (lane 2), in the presence of untreated DNA (lanes
3–5), or in the presence of UV-treated DNA (lanes 6–8), as indicated. Proteins
were separated by SDS/PAGE and visualized by silver staining (Bottom), and
phosphorylated p53 was detected by PhosphorImager (Top). (B) Quantitative
analysis of ATR kinase activity. The mean values and standard errors were
calculated from three independent experiments. The relative kinase activity of
ATR is normalized against the highest kinase activity obtained, which was at
UV irradiated DNA concentration of 750 nM.








not known. In the ATR preparations used in the present study,
we do not see the ATRIP subunit, and hence we can state with
relative confidence that the binding properties we observe are
those of the ATR polypeptide itself. Furthermore, that UV
irradiation crosslinked ATR to DNA strongly indicates that
whether or not it is aided by another protein such as ATRIP,
ATR is in direct contact with DNA. The effect of ATRIP on the
DNA-binding and kinase activities of ATR is currently under
investigation.
UV-induced checkpoint response depends on ATR. However,
in contrast to ATM, whose kinase activity increases after ion-
izing radiation, when ATR is purified from UV- and IR-treated
cells, it does not exhibit increased kinase activity (1). Neverthe-
less, it has been found that Xenopus ATR can be separated by
DNA affinity chromatography (33), and that DNA stimulates the
kinase activity of human ATR (28, 34), suggesting that this
protein as well may bind to DNA and function as a sensor.
However, these experiments do not give a clue why ATR
specifically functions in the UV-induced cell cycle checkpoint. In
fact, studies with Xenopus extracts show that ATR associates
with chromatin on initiation of replication and dissociates on
completion of replication (35), and that the amount of ATR
bound to chromatin increases on inhibiting DNA (but not RNA
primer) synthesis by aphidicolin. These findings have led to the
proposal that ATR binds to the RNA primer or the primer-
associated structure to activate the intrinsic S-phase checkpoint
as well as the G2/M checkpoint. However, two recent studies in
yeast have shown that the counterparts of the ATR–ATRIP
complex can also be recruited to an HO-induced double-strand
break (36, 37), suggesting that ATR may recognize multiple
DNA structures and may not be strictly specific to cell cycle
phase or DNA damage to activate the cell cycle checkpoint. In
addition to ATR and ATM, the checkpoint Rad proteins have
also been implicated in damage sensing. It has been proposed
that either the primary or processed DNA lesions are recognized
by Rad17-RFC, which loads the 9–1-1 complex onto DNA and
in doing so initiates the DNA damage checkpoint response (2,
11) by recruiting and/or activating the ATR kinase to initiate
phosphorylation of downstream effectors. One fission yeast
study raises some doubts about this model (38), where it was
found that the counterpart of ATRIP is phosphorylated by ATR
after DNA damage independently of other checkpoint compo-
nents, including Hus1, Rad1, and Rad9, suggesting that ATR can
be directly activated by DNA damage, which might place the
9–1-1 complex downstream from ATR. Surprisingly, recently
two studies in yeast and one study in humans have shown that the
checkpoint 9–1-1 and ATR-ATRIP complexes or their yeast
counterparts can be recruited to chromatin independently (36,
37, 39). It has also been shown that Rad17 is required for the
recruitment of Rad9 onto chromatin (39). However, at present
there is no direct evidence that Rad17-RFC loads the 9–1-1
complex onto DNA, damaged or undamaged, and interestingly,
the S. cerevisiae homologs of human Rad17 and Rad9 are not
required for cell cycle checkpoint in S-phase.
In summary, currently available evidence from in vivo studies
is insufficient to allow a firm conclusion regarding the roles of
various ‘‘upstream’’ checkpoint proteins in damage sensing and
whether these proteins sense the primary lesion or a common
intermediate resulting from the processing of the various pri-
mary lesions. Within the context of these uncertainties, we
believe that the data presented in this paper constitute the most
compelling evidence to date that in UV-induced checkpoint
response in mammalian cells, at least part of the checkpoint
activation is initiated by binding of ATR to the UV photoprod-
ucts and stimulation of its kinase activity as a consequence of this
binding.
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